Europe • Euronext Paris • EPA:BIM • FR0013280286
Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 63 industry peers in the Health Care Equipment & Supplies industry. BIM has an excellent financial health rating, but there are some minor concerns on its profitability. BIM has a correct valuation and a medium growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.56% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.07 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.13 | ||
| Fwd PE | 18.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.13 | ||
| EV/EBITDA | 11.44 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.92% |
EPA:BIM (2/11/2026, 1:47:37 PM)
93.15
-1.2 (-1.27%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.92% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.13 | ||
| Fwd PE | 18.61 | ||
| P/S | 2.67 | ||
| P/FCF | 25.13 | ||
| P/OCF | 14 | ||
| P/B | 2.8 | ||
| P/tB | 3.94 | ||
| EV/EBITDA | 11.44 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROCE | 11.7% | ||
| ROIC | 8.56% | ||
| ROICexc | 9.38% | ||
| ROICexgc | 13.1% | ||
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% | ||
| FCFM | 10.65% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 73.43% | ||
| Cap/Sales | 8.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.94% | ||
| Profit Quality | 116.09% | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.07 |
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
ChartMill assigns a valuation rating of 5 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.
The dividend rating of BIOMERIEUX (BIM.PA) is 4 / 10 and the dividend payout ratio is 28.07%.